However, in type 2 diabetes, both GLP-1 secretion and activity are impaired, leading to insufficient insulin release and excessive glucagon levels, which exacerbate glucose dysregulation (Bossart et al., 2022). This evidence concerns the gene INS and type 2 diabetes mellitus.